Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Klotho Is a Neuroprotective and Cognition-Enhancing Protein.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
Comprehensive Immunophenotyping of CSF cells in relapsing-remitting multiple sclerosis patients with daclizumb therapy
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
[Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine].
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Posturography in MS patients treated with high dose methylprednisolone.
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial.
Regulation of B cell function by the immunosuppressive agent leflunomide.
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
Circulating innate lymphoid cells are unchanged in response to DAC HYP therapy.
Ampyra (dalfampridine)
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
Autoimmunity in visual loss.
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)

Pages